Dulaglutide improves kidney fibrosis biomarker levels in patients with type 2 diabetes and moderate-to-severe chronic kidney disease

Category Primary study
JournalDiabetes
Year 2020
This article has no abstract
Epistemonikos ID: b4f5f7ba0cfab6954b19d6fbcde19d39f4f3a500
First added on: Feb 12, 2025